PATENT CLAIM ANALYSIS

Application Number: 15977988
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["424", "136100"]

Abstract:
Provided herein are mesothelin (MSLN) targeting trispecific proteins comprising a domain binding to CD3, a half-life extension domain, and a domain binding to MSLN. Also provided are pharmaceutical compositions thereof, as well as nucleic acids, recombinant expression vectors and host cells for making such MSLN targeting trispecific proteins. Also disclosed are methods of using the disclosed MSLN targeting trispecific proteins in the prevention, and/or treatment of diseases, conditions and disorders.

Claim (Index 7):
The MSLN binding trispecific protein of  claim 6 , wherein said third domain comprises a VHH domain.

Metadata:
- Claim Count in Document: 48.0
- Percentile: 93.0
- Lexical Diversity: 1.62
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15977968', '15141463', '15160984', '15105082', '15866222']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7938286465280596
- 35 USC 102 Novelty (BERT): 0.5829584562469983
- Combined Prediction Score: 0.7727416274999535
- Mean Citation Score: 426.53407
- Max Citation Score: 616.45154
- Similarity Product: 370.9363496006751

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test